midazolam has been researched along with Neonatal Abstinence Syndrome in 2 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Neonatal Abstinence Syndrome: Fetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancy. Withdrawal or abstinence symptoms develop shortly after birth. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and gastrointestinal disturbances.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carter, BS | 1 |
| Brunkhorst, J | 1 |
| Biswas, AK | 1 |
| Feldman, BL | 1 |
| Davis, DH | 1 |
| Zintz, EA | 1 |
1 review available for midazolam and Neonatal Abstinence Syndrome
| Article | Year |
|---|---|
Neonatal pain management.
Topics: Amines; Analgesics, Opioid; Anti-Anxiety Agents; Barbiturates; Chronic Pain; Cyclohexanecarboxylic A | 2017 |
1 other study available for midazolam and Neonatal Abstinence Syndrome
| Article | Year |
|---|---|
Myocardial ischemia as a result of severe benzodiazepine and opioid withdrawal.
Topics: Adjuvants, Anesthesia; Analgesics, Opioid; Benzodiazepines; Diazepam; Electrocardiography; Female; F | 2005 |